220 related articles for article (PubMed ID: 18558425)
1. Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantation.
Katsaros KM; Kastl SP; Huber K; Zorn G; Maurer G; Glogar D; Wojta J; Christ G; Speidl WS
Thromb Res; 2008; 123(1):79-84. PubMed ID: 18558425
[TBL] [Abstract][Full Text] [Related]
2. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
Motovska Z; Kala P
Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
[TBL] [Abstract][Full Text] [Related]
3. Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stenting.
Weltermann A; Fritsch P; Kyrle PA; Schoenauer V; Heinze G; Wojta J; Christ G; Huber K
Thromb Res; 2003; 112(1-2):19-24. PubMed ID: 15013268
[TBL] [Abstract][Full Text] [Related]
4. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
[TBL] [Abstract][Full Text] [Related]
5. Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome.
Lemesle G; Delhaye C; Sudre A; Broucqsault D; Rosey G; Bauters C; Lablanche JM
Am Heart J; 2009 Feb; 157(2):375-82. PubMed ID: 19185648
[TBL] [Abstract][Full Text] [Related]
6. Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention.
Quinn MJ; Bhatt DL; Zidar F; Vivekananthan D; Chew DP; Ellis SG; Plow E; Topol EJ
Am J Cardiol; 2004 Mar; 93(6):679-84. PubMed ID: 15019868
[TBL] [Abstract][Full Text] [Related]
7. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement.
Hochholzer W; Trenk D; Bestehorn HP; Fischer B; Valina CM; Ferenc M; Gick M; Caputo A; Büttner HJ; Neumann FJ
J Am Coll Cardiol; 2006 Nov; 48(9):1742-50. PubMed ID: 17084243
[TBL] [Abstract][Full Text] [Related]
8. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use.
Sabatine MS; Hamdalla HN; Mehta SR; Fox KA; Topol EJ; Steinhubl SR; Cannon CP
Am Heart J; 2008 May; 155(5):910-7. PubMed ID: 18440341
[TBL] [Abstract][Full Text] [Related]
10. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
Almagor M; Keren A; Banai S
Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
[TBL] [Abstract][Full Text] [Related]
11. Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention.
Muller O; Hamilos M; Bartunek J; Ulrichts H; Mangiacapra F; Holz JB; Ntalianis A; Trana C; Dierickx K; Vercruysse K; De Bruyne B; Wijns W; Barbato E
Am J Cardiol; 2010 Feb; 105(3):333-8. PubMed ID: 20102944
[TBL] [Abstract][Full Text] [Related]
12. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
[TBL] [Abstract][Full Text] [Related]
14. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris.
Saleh N; Svane B; Jensen J; Hansson LO; Nordin M; Tornvall P
Am Heart J; 2005 May; 149(5):876-82. PubMed ID: 15894971
[TBL] [Abstract][Full Text] [Related]
15. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.
Cuisset T; Frere C; Quilici J; Gaborit B; Castelli C; Poyet R; Bali L; Morange PE; Alessi MC; Bonnet JL
Am J Cardiol; 2009 Oct; 104(8):1078-82. PubMed ID: 19801028
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the impact of short (<1 year) and long-term (> or =1 year) clopidogrel use following percutaneous coronary intervention on mortality.
Banerjee S; Varghese C; Samuel J; Weideman RA; Little BB; Kelly KC; Rao SV; Reilly RF; Brilakis ES
Am J Cardiol; 2008 Nov; 102(9):1159-62. PubMed ID: 18940284
[TBL] [Abstract][Full Text] [Related]
17. A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation.
Han YL; Wang B; Li Y; Xu K; Wang SL; Jing QM; Wang ZL; Wang DM; Ma YY; Wang G
Chin Med J (Engl); 2009 Apr; 122(7):793-7. PubMed ID: 19493391
[TBL] [Abstract][Full Text] [Related]
18. [Optimal platelet inhibition after coronary stent implantation. Current status].
Silber S; Hoffmeister HM; Bode C
Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
[TBL] [Abstract][Full Text] [Related]
19. Prolonged application of clopidogrel reduces inflammation after percutaneous coronary intervention in the porcine model.
Ayral Y; Rauch U; Goldin-Lang P; Stellbaum C; Deiner C; Schwimmbeck PL; Schultheiss HP; Pels K
Cardiovasc Revasc Med; 2007; 8(3):183-8. PubMed ID: 17765648
[TBL] [Abstract][Full Text] [Related]
20. Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort.
Szük T; Gyöngyösi M; Homorodi N; Kristóf E; Király C; Edes IF; Facskó A; Pavo N; Sodeck G; Strehblow C; Farhan S; Maurer G; Glogar D; Domanovits H; Huber K; Edes I
Am Heart J; 2007 Feb; 153(2):289-95. PubMed ID: 17239691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]